Literature DB >> 20799004

Genomic profiles in B cell lymphoma.

Masao Seto1.   

Abstract

Chromosome translocations found in B cell lymphomas generate typical genome profiles that are characteristic of each disease entity. The mechanisms of lymphomagenesis have been investigated with respect to the involvement of deregulated genes in tumor development, as characterized by the promotion of cell proliferation and the blockage of cell differentiation and anti-apoptosis. It is now well known that chromosome translocation alone does not induce tumor formation. New technology such as array CGH and expression profiling introduced as a result of the human genome project introduced a new paradigm from which to understand the molecular mechanisms of lymphoma development. Analyses with this new technology revealed that genome profiles of disease entities are characteristic and differ from disease to disease, although the genome profile of each patient with the same disease entity varies significantly given the recurrent genetic alterations frequently found. These apparent paradoxical findings are likely to be the cause of heterogeneity of the clinicopathological features associated with the same disease entity. Based on these findings, the future prospect and direction of lymphoma research will be discussed.

Entities:  

Mesh:

Year:  2010        PMID: 20799004     DOI: 10.1007/s12185-010-0662-1

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  54 in total

1.  Establishment of a follicular lymphoma cell line (FLK-1) dependent on follicular dendritic cell-like cell line HK.

Authors:  Y Kagami; J Jung; Y S Choi; K Osumi; S Nakamura; Y Morishima; M Seto
Journal:  Leukemia       Date:  2001-01       Impact factor: 11.528

2.  TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma.

Authors:  Keiichiro Honma; Shinobu Tsuzuki; Masao Nakagawa; Sivasundaram Karnan; Yoshifusa Aizawa; Won Seog Kim; Yoon-Duk Kim; Young-Hyeh Ko; Masao Seto
Journal:  Genes Chromosomes Cancer       Date:  2008-01       Impact factor: 5.006

3.  Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances.

Authors:  S Solinas-Toldo; S Lampel; S Stilgenbauer; J Nickolenko; A Benner; H Döhner; T Cremer; P Lichter
Journal:  Genes Chromosomes Cancer       Date:  1997-12       Impact factor: 5.006

4.  Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas.

Authors:  L Zech; U Haglund; K Nilsson; G Klein
Journal:  Int J Cancer       Date:  1976-01-15       Impact factor: 7.396

5.  The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type.

Authors:  G Ott; T Katzenberger; A Greiner; J Kalla; A Rosenwald; U Heinrich; M M Ott; H K Müller-Hermelink
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701

6.  Oncogenic potential of bcl-2 demonstrated by gene transfer.

Authors:  J C Reed; M Cuddy; T Slabiak; C M Croce; P C Nowell
Journal:  Nature       Date:  1988-11-17       Impact factor: 49.962

7.  TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas.

Authors:  Keiichiro Honma; Shinobu Tsuzuki; Masao Nakagawa; Hiroyuki Tagawa; Shigeo Nakamura; Yasuo Morishima; Masao Seto
Journal:  Blood       Date:  2009-07-16       Impact factor: 22.113

8.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays.

Authors:  D Pinkel; R Segraves; D Sudar; S Clark; I Poole; D Kowbel; C Collins; W L Kuo; C Chen; Y Zhai; S H Dairkee; B M Ljung; J W Gray; D G Albertson
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

Review 9.  Translocations among antibody genes in human cancer.

Authors:  P Leder; J Battey; G Lenoir; C Moulding; W Murphy; H Potter; T Stewart; R Taub
Journal:  Science       Date:  1983-11-18       Impact factor: 47.728

10.  Monoclonal antibody against PRAD1/cyclin D1 stains nuclei of tumor cells with translocation or amplification at BCL-1 locus.

Authors:  S Banno; K Yoshikawa; S Nakamura; K Yamamoto; T Seito; M Nitta; T Takahashi; R Ueda; M Seto
Journal:  Jpn J Cancer Res       Date:  1994-09
View more
  5 in total

1.  Synergy of Myc, cell cycle regulators and the Akt pathway in the development of aggressive B-cell lymphoma in a mouse model.

Authors:  K Arita; S Tsuzuki; K Ohshima; T Sugiyama; M Seto
Journal:  Leukemia       Date:  2014-07-18       Impact factor: 11.528

Review 2.  The role of angiogenesis in human non-Hodgkin lymphomas.

Authors:  Domenico Ribatti; Beatrice Nico; Girolamo Ranieri; Giorgina Specchia; Angelo Vacca
Journal:  Neoplasia       Date:  2013-03       Impact factor: 5.715

3.  Predicting interactome network perturbations in human cancer: application to gene fusions in acute lymphoblastic leukemia.

Authors:  Leon Juvenal Hajingabo; Sarah Daakour; Maud Martin; Reinhard Grausenburger; Renate Panzer-Grümayer; Franck Dequiedt; Nicolas Simonis; Jean-Claude Twizere
Journal:  Mol Biol Cell       Date:  2014-10-01       Impact factor: 4.138

4.  Waldenström's macroglobulinemia harbors a unique proteome where Ku70 is severely underexpressed as compared with other B-lymphoproliferative disorders.

Authors:  A Perrot; C Pionneau; N Azar; C Baillou; F M Lemoine; V Leblond; H Merle-Béral; M-C Béné; R Herbrecht; S Bahram; L Vallat
Journal:  Blood Cancer J       Date:  2012-09-07       Impact factor: 11.037

5.  Systematic interactome mapping of acute lymphoblastic leukemia cancer gene products reveals EXT-1 tumor suppressor as a Notch1 and FBWX7 common interactor.

Authors:  Sarah Daakour; Leon Juvenal Hajingabo; Despoina Kerselidou; Aurelie Devresse; Richard Kettmann; Nicolas Simonis; Franck Dequiedt; Jean-Claude Twizere
Journal:  BMC Cancer       Date:  2016-05-26       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.